XML 60 R51.htm IDEA: XBRL DOCUMENT v3.19.2
SHARE-BASED COMPENSATION (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Jul. 28, 2019
Jul. 29, 2018
Jul. 28, 2019
Jul. 29, 2018
Share-based Compensation [Abstract]        
Maximum number of shares of common stock that may be issued (in shares) 4,000,000   4,000,000  
Share-based compensation expense incurred $ 900 $ 800 $ 2,900 $ 2,400
Cash received from option exercises 200 200 1,000 3,800
Share-based compensation cost capitalized 0 0 0 0
Income tax benefits realized from stock option exercises $ 0 $ 0 $ 0 $ 0
Stock Options [Member]        
Share-based Compensation [Abstract]        
Contractual term     10 years  
Additional disclosures [Abstract]        
Share options granted (in shares) 0 12,000 132,000 264,000
Weighted-average grant date fair value of options granted (in dollars per share)   $ 2.84 $ 3.31 $ 2.74
Unrecognized compensation cost related to unvested option awards $ 1,000   $ 1,000  
Period for recognition of compensation cost not yet recognized     2 years 3 months 18 days  
Weighted-average inputs and risk-free rate of return ranges used to calculate the grant date fair value of options [Abstract]        
Volatility   32.30% 33.10% 31.70%
Risk free rate of return   2.80%    
Dividend yield   0.00% 0.00% 0.00%
Expected term   5 years 1 month 6 days 5 years 1 month 6 days 5 years
Outstanding and exercisable option awards [Roll Forward]        
Outstanding at end of period (in shares) 2,366,868   2,366,868  
Exercisable at end of period (in shares) 1,785,201   1,785,201  
Weighted Average Exercise Price [Abstract]        
Weighted average exercise price, Outstanding at end of period (in dollars per share) $ 8.95   $ 8.95  
Weighted average exercise price, Exercisable at end of period (in dollars per share) $ 8.57   $ 8.57  
Weighted-Average Remaining Contractual Life [Abstract]        
Weighted average remaining contractual life, Outstanding at end of period     5 years 7 months 6 days  
Weighted average remaining contractual life, Exercisable at end of period     4 years 8 months 12 days  
Aggregate Intrinsic Value [Abstract]        
Aggregate intrinsic value, Outstanding at end of period $ 3,288   $ 3,288  
Aggregate intrinsic value, Exercisable at end of period $ 3,060   $ 3,060  
Stock Options [Member] | Minimum [Member]        
Share-based Compensation [Abstract]        
Award vesting period     1 year  
Weighted-average inputs and risk-free rate of return ranges used to calculate the grant date fair value of options [Abstract]        
Risk free rate of return     2.50% 2.20%
Stock Options [Member] | Maximum [Member]        
Share-based Compensation [Abstract]        
Award vesting period     4 years  
Weighted-average inputs and risk-free rate of return ranges used to calculate the grant date fair value of options [Abstract]        
Risk free rate of return     2.90% 2.80%
Restricted Stock [Member]        
Additional disclosures [Abstract]        
Period for recognition of compensation cost not yet recognized     2 years 8 months 12 days  
Restricted Stock [Abstract]        
Restricted stock awards granted (in shares) 0 0 435,000 290,000
Weighted average grant date fair value of restricted stock awards (in dollars per share)     $ 9.80 $ 8.62
Compensation cost not yet recognized related to unvested restricted stock awards $ 5,000   $ 5,000  
Number of shares of restricted stock outstanding (in shares) 676,863   676,863  
Restricted Stock [Member] | Minimum [Member]        
Share-based Compensation [Abstract]        
Award vesting period     1 year  
Restricted Stock [Member] | Maximum [Member]        
Share-based Compensation [Abstract]        
Award vesting period     4 years